Introduction
Focal white matter lesions (WMLs) characterized by inflammation, demyelination, remyelination, edema, axonal damage, and gliosis are easily visible on brain MRI and are present in more than 90% of patients with clinically definite multiple sclerosis (MS) (1) (2) (3) (4) . Previously, 3 family and 3 twin studies have investigated the incidence of such lesions in clinically asymptomatic subjects with a genetic susceptibility to MS by using specific magnetic resonance imaging (MRI) criteria (5) (6) (7) (8) (9) (10) . According to these studies, MS-like lesions can be detected in 4%-10% of asymptomatic subjects having a first degree relative with MS. On the other hand, autopsy studies have revealed that the prevalence of MS-like brain WMLs in healthy subjects with no risk of MS is equivalent to the prevalence of MS in the general population of the United States (0.1% of the population) (11) (12) (13) . In addition to focal WMLs, brain atrophy starts to develop in the majority of MS patients, often from the very onset of the disease (14) (15) (16) . The annual decrease in the brain volume in healthy subjects is approximately 0.1%-0.3% (17, 18) , whereas in MS patients, it is 0.6%-1.0% (18) (19) (20) . According to the recent studies, brain size, white matter (WM) hyperintensity, and the development of brain atrophy are highly heritable (21) (22) (23) (24) (25) (26) (27) (28) .
A registry-based co-twin control method was used to evaluate the degree of brain atrophy in twins with MS and their asymptomatic co-twins. In order to evaluate the possibility of so-called subclinical MS in asymptomatic twins, the presence and volumes of focal WMLs were evaluated both in the brain and the spinal cord (SC), which is not known to be affected by aging (29) .
Material and Methods
Seven monozygotic (MZ) and 12 dizygotic (DZ) twin pairs discordant for MS, obtained from the Finnish Twin Cohort (30) , participated in this study. All subjects provided written informed consent before the study entry. The study was approved by the Ethics Committee of Tampere University Hospital. The collection of the study population and verification of MS diagnosis have been described in detail previously (30) . All subjects underwent a neurological examination by the same neurologist (H.K.). The diagnosis of MS was based on the McDonald's (2) criteria of clinically definite MS. All twins had remission at the time of the study. The clinical characteristics of the twins are shown in Tables 1, 2 , and 3. Three twins with MS had a coexisting dis-ease: 1 twin had atrial fibrillation, the second had eosinophilic pneumonia, and the third suffered from asthma. Nine of the co-twins had also some chronic diseases, with hypertension, psoriasis, and asthma being the most common (each in 2 subjects). The diseases of the co-twins presenting with WMLs are shown in Table 3 . The individual study results were provided to all subjects after the MRI evaluation.
Magnetic MRI evaluation was undertaken blindly from coded pictures by an experienced neuroradiologist (P.D.). Examinations were performed using the same scanner (GE Signa Horizon LX, Wisconsin, USA). Axial 3-dimensional (3D) T2 fast spin echo (FSE), T1 3D axial spoiled gradient echo (SPGR), and FLAIR sequences were used to perform volumetric analyses of plaques and brain volumes. The sagittal 3D T2 FSE sequence was used to perform analyses of the SC and spinal canal volumes. Good head repositioning was controlled using the same head coil, the same anatomic locations, and the same pack of images in different MRI sequences. The SC was scanned by separating it into the upper (cervico-thoracic) and lower (thoraco-lumbar) parts.
Image Analysis of Plaques and Atrophy. T2 hyperintense plaques were analyzed from 3D T2 FSE images, T1 hypointense plaques from 3D T1 SPGR images, and FLAIR lesions from FLAIR images. Brain volumes were analyzed from 3D T1 FSE images. First, the total intracranial volume was measured adding both the total cerebral volume and the total cerebrospinal fluid. The ratio of the total cerebral volume to the total intracranial volume was used as a marker of cerebral atrophy. The SC and spinal canal volumes were analyzed from sagittal 3D T2 FSE images, and the ratio of the SC volume to the spinal canal volume was used as a marker of SC atrophy. Since the FLAIR sequence was not 3D in nature, the lesion volumes in the gap between 2 slices were estimated by multiplying the average cross-sectional area of the plaque structures by the gap thickness. The total number and location of the MRI lesions were analyzed by using the criteria of Barkhof (31) .
Statistical data analysis was performed using the SPSS for Windows, version 14.0.2. P values less than 0.05 were considered statistically significant. Due to the skewed distributions, continuous variables were expressed as medians and ranges, and differences between asymptomatic twins and twins with MS were tested by paired exact signed test.
Results
No significant differences were found in brain (P=0.064) or SC (P=0.648) volumes between the twins with MS and their co-twins (Table 4 ). All 19 twins with MS had focal brain WMLs, and 14 of them (74%) fulfilled the MRI criteria of Barkhof ( Table 2) . Nine of the 19 (4/7 MZ and 5/12 DZ) co-twins had focal brain WMLs seen on T1, T2, or FLAIR images, but the MRI criteria of Barkhof were not fulfilled in any of these subjects ( Table 2 ). All but one of the co-twins presenting with WMLs was over 50 years. The remaining one had excessive alcohol consumption as a risk factor for the development of WMLs. Of the 9 co-twins presenting with WMLs, 7 had a chronic disease, and of the 10 co-twins with no WMLs, 2 had a chronic disease (asthma and hypertension). Three twins with MS had a SC lesion, but no such lesions were present among the co-twins ( Table 2 ). The volumetric results of twins with MS and their co-twins are presented in Table 4 . In the subgroup of co-twins with focal brain WML (n=9), the volumes of T1 (P=0.016), T2 (P=0.039), and FLAIR lesions (P=0.004) were significantly smaller than in the twins with MS (n=19).
Discussion
Even though the annual decrease in brain volume of MS patients is 10-fold compared with healthy people (18, 19) , the brain size in a genetically homogenous patients' population such as the twins discordant for MS appeared to be without a marked difference. Our findings may be explained by a recent observation indicating that the brain size is a highly heritable parameter, and the development of generalized brain atrophy may be genetically regulated (21, 22) . The genetic contribution to the volume of the lateral ventricles has been shown to increase with age, accounting for 75% of the variance after middle age (22) . In addition to genes, twins share many environmental factors during the fetal life, childhood, and adolescence, such as nutrition, sunlight exposure (vitamin D), passive smoking by the parents, and various infections, some of which may also influence the brain size and the rate of atrophy making it difficult to detect a difference in brain size in diseased and asymptomatic subjects. In MS, both gray and WM regions are affected by atrophy, but their pathogenesis differs (32) . In WM, atrophy results mainly from the focal loss of myelin and axon density due to inflammation (32, 33) , whereas gray matter atrophy is caused by direct axonal injury that predominates especially in secondary progressive MS (SPMS) (34) . When adjusted to the baseline brain volume, overall brain atrophy develops throughout the course of MS at the rate, which is independent of the disease subtype (35) . However, the mechanisms of atrophy in relapsing remitting MS (RRMS) and SPMS differ. Early in the disease process that is predominantly characterized by inflammatory activity, atrophy affects both white and gray matter, whereas on transition to the SPMS phase, atrophic changes of gray matter start to prevail (34) . Since the median age of our twins was more than 50 years and the median duration of MS was more than 10 years, it is likely that both inflammatory and degenerative mechanisms have contributed to the development of loss in the brain volume. Even so, we could not detect a difference in brain volume between our groups, most likely because twins share both genes and environmental factors that may regulate the brain size and the rate of brain atrophy due to normal aging.
Radiological studies performed on MS patients have revealed a frequent involvement of SC even in the absence of any spinal symptoms or signs. When evaluating the clinical significance of WM lesions in the central nervous system (CNS) in asymptomatic subjects, MRI of the SC is especially valuable since the SC is not affected by aging (29) . In the present study, we could not detect WMLs in the SC of the asymptomatic co-twins, though they were a frequent event in the brain, especially in subjects aged more than 50 years and with chronic diseases. However, the volume of these lesions was small, and none of the co-twins presenting with WMLs fulfilled the Barkhof 's MRI criteria (31) , indicating that they might be related to age and existing risk factors (Table 3) rather than so-called subclinical MS characterized by the presence of oligoclonal bands in cerebrospinal fluid and/or silent WMLs on brain MRI. Our results are in line with the findings of DeStefano and colleagues, who proposed that even though there is a genetic susceptibility to the development of brain WMLs in first-degree relatives of MS patients, they do not lead to widespread tissue damage and clinical MS disease (35) . Due to the limited number of twins in this study, we cannot however exclude the possibility of subclinical MS in this genetically at risk population, even though our findings did not support the idea.
The relation between WMLs and brain atrophy has been found in various diseases including MS (36, 37) as well as in asymptomatic elderly people. Whether this is independent of shared vascular risk factors has yet to be shown (37) . Since the common vascular risk factors including hypertension, hyperlipidemia, obesity, diabetes mellitus, and smoking have been found to be associated with both the development of WML and brain atrophy, it has been suggested that vascular mechanisms contribute to the progression of brain atrophy during aging (37) (38) (39) (40) (41) (42) (43) (44) . On the other hand, WM hyperintensity has been shown to be highly heritable, and therefore, a good genetic marker for brain aging even in subjects with the low prevalence of cerebrovascular brain injury (23) . In the present study, no difference in brain volumes between twins with MS and co-twins was found even though there was a significant difference in WML volumes. This result supports the previous findings that the brain volume in twins is highly heritable (23, 24) . It should be noted that our study was not designed to evaluate the association of WMLs and brain atrophy in twins with MS or their co-twins, and therefore, the study population is too small to make any such correlations.
Conclusions
The lack of a significant difference in the brain or spinal cord volumes between twins with multiple sclerosis and their co-twins is most likely to be explained by the recent observation showing the brain size and the development of brain atrophy being highly heritable.
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